| The pathogenesis of sepsis DJ Stearns-Kurosawa, MF Osuchowski, C Valentine, S Kurosawa, ... Annual review of pathology: mechanisms of disease 6, 19-48, 2011 | 777 | 2011 |
| Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality MF Osuchowski, K Welch, J Siddiqui, DG Remick The Journal of Immunology 177 (3), 1967-1974, 2006 | 741 | 2006 |
| Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding KN Iskander, MF Osuchowski, DJ Stearns-Kurosawa, S Kurosawa, ... Physiological reviews 93 (3), 1247-1288, 2013 | 539 | 2013 |
| The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity MF Osuchowski, MS Winkler, T Skirecki, S Cajander, M Shankar-Hari, ... The Lancet Respiratory Medicine 9 (6), 622-642, 2021 | 473 | 2021 |
| Current gaps in sepsis immunology: new opportunities for translational research I Rubio, MF Osuchowski, M Shankar-Hari, T Skirecki, MS Winkler, ... The Lancet infectious diseases 19 (12), e422-e436, 2019 | 265 | 2019 |
| Minimum Quality Threshold in Pre-Clinical Sepsis Studies (MQTiPSS): An International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis FM Osuchowski, A Ayala, S Bahrami, M Bauer, M Boros, JM Cavaillon, ... SHOCK 50 (4), 377-380, 2018 | 245 | 2018 |
| The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APPsw mice J Wegiel, KC Wang, H Imaki, R Rubenstein, A Wronska, M Osuchowski, ... Neurobiology of aging 22 (1), 49-61, 2001 | 192 | 2001 |
| Abandon the mouse research ship? Not just yet! MF Osuchowski, DG Remick, JA Lederer, CH Lang, AO Aasen, M Aibiki, ... Shock 41 (6), 463-475, 2014 | 177 | 2014 |
| Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis MF Osuchowski, J Connett, K Welch, J Granger, DG Remick Critical care medicine 37 (5), 1567-1573, 2009 | 160 | 2009 |
| Sepsis chronically in MARS: systemic cytokine responses are always mixed regardless of the outcome, magnitude, or phase of sepsis MF Osuchowski, F Craciun, KM Weixelbaumer, ER Duffy, DG Remick The Journal of Immunology 189 (9), 4648-4656, 2012 | 132 | 2012 |
| Chronic sepsis mortality characterized by an individualized inflammatory response MF Osuchowski, K Welch, H Yang, J Siddiqui, DG Remick The Journal of Immunology 179 (1), 623-630, 2007 | 106 | 2007 |
| Protective role of peroxisome proliferator–activated receptor-β/δ in septic shock A Kapoor, Y Shintani, M Collino, MF Osuchowski, D Busch, NSA Patel, ... American journal of respiratory and critical care medicine 182 (12), 1506-1515, 2010 | 94 | 2010 |
| Cecal ligation and puncture-induced murine sepsis does not cause lung injury KN Iskander, FL Craciun, DM Stepien, ER Duffy, J Kim, R Moitra, ... Critical care medicine 41 (1), 159-170, 2013 | 85 | 2013 |
| Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice J Wegiel, H Imaki, KC Wang, J Wegiel, A Wronska, M Osuchowski, ... Acta neuropathologica 105, 393-402, 2003 | 76 | 2003 |
| Physiological responses of a natural antioxidant flavonoid mixture, silymarin, in BALB/c mice VJ Johnson, Q He, MF Osuchowski, RP Sharma Planta medica 69 (01), 44-49, 2003 | 73 | 2003 |
| Part I: minimum quality threshold in preclinical sepsis studies (MQTiPSS) for study design and humane modeling endpoints B Zingarelli, CM Coopersmith, S Drechsler, P Efron, JC Marshall, ... Shock 51 (1), 10-22, 2019 | 66 | 2019 |
| SARS-CoV-2/COVID-19: evolving reality, global response, knowledge gaps, and opportunities MF Osuchowski, F Aletti, JM Cavaillon, SB Flohe, ... Shock 54 (4), 416-437, 2020 | 61 | 2020 |
| Alterations in regional brain neurotransmitters by silymarin, a natural antioxidant flavonoid mixture, in BALB/c mice M Osuchowski, V Johnson, Q He, R Sharma Pharmaceutical biology 42 (4-5), 384-389, 2004 | 60 | 2004 |
| Relationship between age/gender-induced survival changes and the magnitude of inflammatory activation and organ dysfunction in post-traumatic sepsis S Drechsler, K Weixelbaumer, P Raeven, M Jafarmadar, A Khadem, ... PloS one 7 (12), e51457, 2012 | 58 | 2012 |
| Part II: minimum quality threshold in preclinical sepsis studies (MQTiPSS) for types of infections and organ dysfunction endpoints C Libert, A Ayala, M Bauer, JM Cavaillon, C Deutschman, C Frostell, ... Shock 51 (1), 23-32, 2019 | 54 | 2019 |
